TON May 2016 Vol 9 No 3

  • ASCO Issues Guidelines for Developing Clinical Pathways That Promote Value-Based Care
  • Second Cancer Risk Is High After Hodgkin Lymphoma
  • Cancer Screening May Not Save Lives, a New Analysis Suggests
In the past few years, some of the classic phenotypes and associated cancer risk estimates of inherited cancer syndromes have been questioned. This is due partly to increased access to genetic testing as well as to the availability of next-generation sequencing (NGS) panels for inherited cancer.
A steroid mouthwash can reduce the incidence of stomatitis associated with the use of everoli­mus. Data from the first prospective trial of prophylactic use of a steroid mouth rinse demonstrated a 26% incidence of stomatitis among patients with metastatic breast cancer who used the mouth rinse versus 67% in historical controls.
At the 2016 Cancer Survivorship Symposium, Anthony L. Back, MD, Fred Hutchinson Cancer Research Center, University of Washington, highlighted 4 pivotal conversations that all cancer care providers must face, offering the requisite communication skills for helping patients cope with their disease.
Preliminary results from a prospective study suggest that assessing psychological factors in cancer patients prior to initiating therapy can identify patients most at risk for emotional distress who might need psychosocial support.
Increased levels of physical activity after a diagnosis of prostate cancer are associated with significantly better survival, according to the results of a new, large prospective cohort study.
Bone mineral density testing is underutilized in women with BRCA mutations who undergo risk-reducing salpingo-oophorectomy (RRSO). In a review of health surveillance data from a single institution, only about half of these women were screened for osteoporosis using dual-energy x-ray absorptiometry (DEXA) scan, despite being at significantly increased risk for the disease.
Linking physicians and patients is a major undertaking, but given the ubiquity of smartphone technology and the rise in app development, the healthcare industry is poised to leverage advances in communication and information exchange.
San Antonio, TX–A scalp cooling system protects against chemotherapy-induced hair loss in patients with breast cancer, and contributes to their well-being. The effects of the DigniCap scalp cooling system in 110 patients were presented at the 2015 San Antonio Breast Cancer Symposium.
This therapy is indicated for the treatment of adults and children with hepatic veno-occlusive disease (VOD) who develop renal or pulmonary dysfunction after undergoing hematopoietic SCT.
Page 2 of 2
Results 11 - 20 of 20